EnteregŪ (alvimopan) capsules is now available to registered hospitals for helping patients recover gastrointestinal (GI) function earlier following bowel resection surgery. Entereg was approved by the U.S. Food and Drug Administration (FDA) on May 20, 2008, and is the first FDA-approved treatment for postoperative ileus (POI), a condition that affects almost all patients undergoing this type of surgery.

More: continued here

This entry was posted on Wednesday, June 11th, 2008 at 8:06 pm and is filed under GastroIntestinal / Gastroentorology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.